Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible <i>Staphylococcus aureus</i> in a Tertiary Care University Hospital

• المؤلفون الرئيسيون: Atsushi Uda (مؤلف), Kenichiro Onuma (مؤلف), Katsumi Shigemura (مؤلف), Koichi Kitagawa (مؤلف), Yonmin Yan (مؤلف), Kayo Osawa (مؤلف), Ikuko Yano (مؤلف), Takayuki Miyara (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2021-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible <i>Staphylococcus</i><i>aureus</i> (MSSA). In March 2019, problems with a major antibiotic supplier cause...